Abstract: A simple, sensitive, reproducible and specific stability indicating high performance liquid chromatographic method for the simultaneous estimation of amlodipine besylate (AMD) and benazepril hydrochloride (BEZ) in their combined drug product was developed and validated. Risperidone (RIS) was used as internal standard. AMD and BEZ were separated and quantitated on a Hichrom 5 C8 column (250 × 4.6 mm i.d., 5 μm particle size) using a mixture of methanol-formic acid 0.1 M (63:37, v/v) as a mobile phase and at a flow rate of 0.9 mL min -1 . The retention times were about 3.7, 5.3 and 7.3 min for RIS, BEZ and AMD, respectively. Quantification was achieved with an UV detector at 242 nm over the concentration ranges of 0.85-807.0 μg mL -1 for BEZ and 0.32-785.0 μg mL -1 for AMD. The limits of detection were 0.18 and 0.12 μg mL -1 for BEZ and AMD, respectively. The method was validated as per the International Conference on Harmonization (ICH) guidelines. AMD and BEZ stock solutions were subjected to different stress conditions. The degraded product peaks were well resolved from the pure drug peak with significant difference in their retention time values. Stressed samples were assayed using developed HPLC method. The method is also demonstrated to be robust, because it is resistant to small variations of chromatographic variables such as pH, mobile phase composition and flow rate. The proposed method is found to be very sensitive and accurate for the determination of AMD and BEZ in combined capsule dosage form.
INTRODUCTION
Amlodipine (as besylate) is in a class of drugs called beta-blockers. Beta-blockers affect the heart and circulatory system (arteries and veins). Amlodipine besylate (AMD) is used to lower blood pressure, lower heart rate, reduce chest pain (angina), and to reduce the risk of recurrent heart attacks. It is chemically described as 2-[(2-amino ethoxy-(methyl]-4-(2-cholophenyl)-1,4-dihydro-6-methyl-3,5-pyridine dicarboxylic acid 3-ethyl-5-methyl ester, benzosulfonate [1] .
Benazepril hydrochloride (BEZ) and its active metabolite benazeprilat are non-sulfhydryl angiotensin converting enzyme (ACE) inhibitors. ACE is a peptidyldipeptidase that catalyses the conversion of angiotensin I intoangiotensin II, a vasoconstrictor substance. As BEZ inhibits ACE, it ultimately results in reduction in vasoconstriction and is used in the treatment of hypertension. It is chemically 1H-1-benzazepine-1-acetic acid, 3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, monohydrochloride, [S-(R*,R*)]-; (3S)-3-[[(1S)-1-carboxy-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, 3-ethyl ester, monohydrochloride. The combination therapy of AMD and BEZ was shown to be superior in lowering systolic and diastolic blood pressures when compared with either of the monotherapy regimens [2] . These two drugs are marketed as combined dose capsule formulation in the ratio of 1:4 (AMD:BEZ). Both the drugs amlodipine and benazepril are official with BP as individual monographs [3] .
Few analytical methods for the determination of amlodipine besylate and benazepril hydrochloride in combined dosage forms including RP-HPLC [4] [5] [6] , spectrophotometry [6, 7] and HPTLC [8] have been reported. Several methods have been reported for the determination of amlodipine with other drugs by UV-spectrophotometry [9] [10] [11] [12] [13] , dual wavelength spectrophotometry [14, 15] , derivative spectrophotometry [16, 17] , kinetic spectrophotometry [18] , HPLC with UV detection [17, [19] [20] [21] [22] [23] [24] [25] [26] [27] , HPLC with PDA detection [28] [29] [30] , HPLC with fluorescence detection [31] , spectrofluorimetry [32] , HPTLC [33] and capillary electrophoresis [34] and amlodipine alone by visible spectrophotometry [35, 36] and voltammetry [37] from pharmaceutical formulations. Benazepril hydrochloride has been determined either alone or with other drugs in pharmaceutical formulations by spectrophotometry [38] [39] [40] [41] [42] , potentiometry [43] , HPTLC [44] and HPLC [44] [45] [46] .
The LC methods [4] [5] [6] reported for the assay of AMD and BEZ in combined pharmaceutical dosage form show lower sensitivity as compared to the proposed method and consequently generates a large amount of solvent (acetonitrile) waste, which may adversely affect the environment, therefore demands expensive disposal process. Further, the absence of an official pharmacopoeial method for estimation of combination of AMD and BEZ motivated the authors to attempt, and to develop a stability indicating HPLC method for the estimation of AMD and BEZ which is simple, rapid, less expensive and environment friendly.
The present study describes the validation of a stability indicating RP-HPLC method, with a simple composition and low cost of mobile phase, which was used for the first time in this work, for the determination of benazepril hydrochloride and amlodipine besylate in raw material and combined capsule formulations. Moreover, the lower solvent consumption leads to an environmentally friendly chromatographic procedure. The method serves as an alternative to the methods described in pharmacopoeias.
EXPERIMENTAL 2.1. Materials
The pure AMD powder was obtained from Hetero Drugs Limited (India), pure BEZ was obtained from Aarti Industries Limited (India) and pure risperidone (RIS) powder from Chempi Fine Chemical (India). The structures of these compounds are shown in Figure 1 . HPLC grade methanol and water were purchased from Merck (Germany). Analytical reagent grade formic acid from Merck (Germany) was used to prepare the mobile phase. Capsules were purchased from Syrian market. 
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HPLC system
The chromatographic system consisted of Hitachi (Japan) Model L-2000 equipped with a binary pump (model L-2130, flow rate range of 0.000-9.999 mL min -1 ), degasser and a column oven (model L-2350, temperature range of 1-85 o C). All samples were injected (10 L) using a Hitachi L-2200
autosampler (injection volume range of 0.1-100 L). Elution of all analytes were monitored at 230 nm by using a Hitachi L-2455 absorbance detector (190-900 nm) containing a quartz flow cell (10 mm path and 13 L volume). Each chromatogram was analyzed and integrated automatically using the Ezchrom Elite Hitachi software.
Chromatographic conditions
Separation was achieved on a reversed phase Hichrom 5 C8 column (250 × 4.6 mm, 5 m particle size, Hichrom Limited, England). The mobile phase was consisted of methanol-0.1 M formic acid (63/37, v/v) and was pumped at a flow rate of 0.9 mL min -1 . The mobile phase was filtered through 0.45 m membrane filter and degassed by ultrasonic agitation before use. The injection volume was 10 L. The system was operated at ambient temperature.
Standard solutions
Standard stock solutions of BEZ and AMD (1.0 mg mL -1 of both) were prepared by direct weighing of standard substance with subsequent dissolution in methanol. From these stock solutions the working standard solutions were prepared by further diluting of stock solution using methanol. Standard solution of RIS (1.0 mg mL -1 ) was prepared by dissolving appropriate amount of the compound in methanol.
These solutions were stored in the dark at 2-8 °C and found to be stable for three weeks at least.
Assay procedure for dosage forms
The entire content of twenty capsules containing BEZ and AMD were weighed and mixed well. Portions of the powder (each equivalent to the weight of five capsules) were accurately weighed into 50 mL volumetric flasks and 30 mL methanol was added. The volumetric flasks were sonicated for 15 min to effect complete dissolution of the BEZ and AMD, the solutions were then made up to volume with methanol. The sample solutions were filtered. The aliquot portions of the filtrate were further diluted to get final concentration of 200 g mL -1 of BEZ and 50 g mL -1 of AMD in the presence of 150 g mL -1 of internal standard. Finally, 10 L of each diluted sample was injected into the column and chromatogram was recorded for the same. Peak area ratios of BEZ and AMD to that of RIS were then measured for the determination.BEZ and AMD concentrations in the samples were then calculated using peak data and standard curves.
Forced degradation studies
To evaluate the stability indicating properties of the developed HPLC method, forced degradation studies were carried out in accordance to the International Conference on Harmonization (ICH) guidelines [47] . The forced degradation was performed in the dark to exclude the possible degradation effect of light. The resulting solutions (200 g mL -1 for BEZ and AMD) were run under optimized chromatographic conditions.
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Dry heat
For dry heat degradation study, the standard powder drugs were placed in an oven at 100 o C for 24 h. Appropriate dilutions were prepared in methanol and then analyzed under the optimized chromatographic conditions.
Photo-degradation study
For the photo-degradation study, the standard powder drugs were exposed to UV light in a photostability chamber for 24 h. Appropriate dilutions were prepared in methanol and then analysed under the optimized chromatographic conditions.
Method validation 2.7.1. Linearity
A series of working standard drug solutions equivalent to 0.85-807.0 μg mL -1 for BEZ and 0.32-785.0 μg mL -1 for AMD were prepared by diluting the stock standard solution with the methanol. In each sample 1.5 mL of RIS was added (150 g mL -1 in the final volume). To construct the calibration curve five replicates (10 μL) of each standard solution were injected immediately after preparation into the column and the peak area of the chromatograms were measured. Then, the mean peak area ratio of BEZ and AMD to that of the internal standard was plotted against the corresponding concentration to obtain the calibration graph.
LOD and LOQ
The sensitivity of the method was determined with respect to LOD and LOQ. The minimum level at which the investigated compounds can be reliably detected (limit of detection, LOD) and quantified (limit of quantitation, LOQ) were determined experimentally. LOD were expressed as the concentration of compound that generated a response to three times of the signal to-noise (S/N) ratio, and LOQ was 10 times of the S/N ratio [48] . The LOD and LOQ parameters were determined from regression equations of BEZ and AMD; LOD (k=3) =k×S a /b, LOQ (k=10) =k×S a /b (where b is the slope of the calibration curve and S a is the standard deviation of the intercept).
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Precision and accuracy
Intra and inter-day precision of the methods were determined by performing replicate (n = 5) analyses of standards and samples. This procedure was replicated on different days (n = 5). Recovery studies were performed in view to justify accuracy of the proposed method. Precision was calculated from percentage relative standard deviation (RSD %) for repeated measurements, whereas accuracy was expressed as % of recovery.
Specificity
The specificity of the method was established through study of resolution factor of drug peaks from nearest resolving peak and also among all other peaks. Peak purity of both BEZ and AMD was assessed to evaluate the specificity of the method. Specificity was also studied by performing the forced degradation study using acid and alkali hydrolysis, chemical oxidation, dry heat and photo degradation studies.
Robustness
Robustness of HPLC method was determined by deliberately varying certain parameters like flow rate, percentage of organic solvent in mobile phase and pH of mobile phase. For all changes in conditions the samples were analysed in triplicate. When the effect altering one set of conditions was tested, the other conditions were held constant at optimum values.
System suitability
The system suitability test was performed to confirm that the LC system to be used was suitable for intended application. A standard solution containing 200 g mL -1 of BEZ and 200 g mL -1 of AMD in the presence of 150 g mL -1 of internal standard were injected seven times. The parameters peak area, retention time, resolution, capacity factor, theoretical plates, tailing factor (peak symmetry) and % RSD were determined.
RESULTS AND DISCUSSION
Optimization of chromatographic conditions
During the analysis of drugs like AMD and BEZ, one of the well known problem in pharmaceutical industry is peak tailing. Since these compounds strongly interact with polar ends of HPLC column packing materials, causing severe peak asymmetry and low separation efficiencies. High purity silica backbone and advances in bonding technology have alleviated the tailing problem of polar compounds in HPLC to a significant extent. RIS was used as internal standard, to improve the analytical performance and thus control undetermined changes in active pharmaceutical ingredient concentration and instrument response fluctuations, and also to reduce the problem of the many-fold dilution required in the classical batch procedures.
Effect of methanol ratio
To obtain the best chromatographic conditions, the mobile phase was optimized to provide sufficient selectivity and sensitivity in a short separation time. The effect of composition of the mobile phase on the retention time of AMD, BEZ and RIS was investigated. During the optimization of the chromatographic method, two organic solvents (acetonitrile and methanol) and different buffers (phosphate, acetate, formic acid, ammonium acetate and citrate) for mobile phase preparation were tested. Formic acid buffer resulted in high sensitivity and better peak shapes compared with other buffers. The effect of pH in the chromatographic elution of the compounds was also investigated by change the concentration of the aqueous component of the mobile phase from 0.03 to 0.15 M. For all experimental ) concentration values, the drugs are eluted in order of RIS, BEZ and AMD. A value of 0.1 M of formic acid was chosen for the optimum separation of the compounds, as at this concentration the analyte peaks were well defined and resolved. With acetonitrile as solvent both the peaks show less theoretical plates and more retention time compared to methanol. The mobile phase used was a mixture of methanol-formic acid 0.1 M in the isocratic elution mode. As a preliminary trial, the standard mixture solution of AMD and BEZ in concentration of 200 g mL -1 for each and RIS in concentration of 150 g mL -1 , was injected into a Hichrom 5 C8 column at 25 o C and eluted with a flow rate of 0.9 mL min -1
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. Results of the effect of methanol in the mobile phase are presented in Figure 2 . An increase in the percentage of methanol decreases the retention of compounds, BEZ, AMD and the internal standard. Increasing methanol percentage to more than 70% BEZ peak is eluted with the solvent front, while at methanol percentage lower than 55% the elution of AMD peak is seriously delayed. The optimum methanol percentage was found to be 63%. For all experimental concentration values, the drugs are eluted in order of RIS, BEZ and AMD. 
Effect of the column type
The effect of column type (packing material) on the separation and determination of AMD and BEZ was investigated using two different C8 columns (Nucleodur, 250 mm × 4.6 mm, 5 m; Hichrom 5, 250 mm × 4.6 mm, 5 m) and two different C18 columns (Nucleodur, 250 mm × 4.6 mm, 5 m; ODS Hypersil, 250 mm × 4.6 mm, 5 m). It was found that Hichrom 5 C8 column gave the most suitable resolution between AMD, BEZ and RIS peaks (>4) according to the pharmacopeial requirement while the other columns cause the peaks of the AMD and BEZ either to be overlapped or to have unsuitable resolution (<4).
HPLC method development
Isocratic elution was used for the determination of AMD, BEZ and its separation from the internal standard (RIS) with good chromatographic characteristic. The use of isocratic elution was proven to be short retention time for the AMD and BEZ peaks and helped in the separation of AMD, BEZ and degradation products. for QC laboratories. The optimum wavelength for detection was at 242 nm, at which the best detector responses for all substances were obtained. 
Method validation 3.2.1. Force degradation
Forced degradations are performed to provide indications of the stability-indicating properties of an analytical method, particularly when there is no information available about the potential degradation products. In total, many degradation products were detected by LC on decomposition of the drugs under specific stress conditions. It was observed that around 10% of BEZ and 5% of AMD degraded on refluxing it in methanolic 0.1 N HCl for 1 hr and there was no corresponding formation of degradation products as compared to the chromatogram of drug in formulation (Figure 4 ). This indicates that the drug was stable in acidic condition.
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BEZ and AMD proved labile on exposure to alkali. Under the conditions, the drugs decomposed to the same major degradation product ( Figure 5 ). About 87% of BEZ and 45% of AMD degradation was observed within 1 hr refluxing in methanolic 0.1 N NaOH. The degradation products of BEZ and AMD were incompletely distinguishable from the parent compound, with new peaks of unknown at 4.24 and 4.64 min, whereas a prominent peaks of BEZ and AMD were stable at 5.41 and 7.37 min. BEZ and AMD proved labile on exposure to 3% H 2 O 2 for 1 hr. In methanolic solution, almost 5% of BEZ and 10% of AMD degraded in 1 hour with formation of a new degradation product peak at 3.28 min (Figure 6 ).
BEZ and AMD were found to be stable after exposing the drug to 100 ºC and UV light (254 nm) for 24 hours. The exposure of the solid drug to 100ºC for 24 hours shows no degradation. It indicated that BEZ and AMD were found to be highly stable to dry heat and UV light than other force degradation condition. Table 1 indicates the extent of degradation of BEZ and AMD under various stress conditions. Stability data for the degradation of BEZ and AMD were analyzed according to the ICH guidelines. 
System suitability
The suitability of the chromatographic system was demonstrated by comparing the obtained parameter values, reported in Table 2 , with the acceptance criteria of the CDER guidance document. The system suitability requirements for BEZ and AMD in the presence of internal standard was a %RSD for peak area less than 0.8, a peak tailing factor less than 1.2 and a R s greater than 5.0 between adjacent peaks for all analytes. This method met these requirements. The results are shown in Table 2 .
Specificity
The specificity of the method was established through study of resolution factor of drug peaks from nearest resolving peak and also among all other peaks. The specificity of the chromatographic method was determined to ensure separation of BEZ, AMD and the internal standard as illustrated in Figure 3 where complete separation of BEZ and AMD was noticed. The HPLC chromatogram recorded for the analytes in capsule (Figure 7) showed almost no peaks within a retention time range of 15 min. The figures show that BEZ and AMD are clearly separated and the peak of analytes were pure and excipients in the formulation did not interfere the analytes indicate specific nature of the method. The results from
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the stress testing studies indicated that the method was highly specific for BEZ and AMD.
Linearity and limits of detection and quantification
For quantitative applications linear calibration graphs were obtained with correlation coefficients of the regression equations greater than 0.999 in all cases and results are summarized in Table 3 . Calibration plots were linear for 0.85-807.0 µg mL -1 and 0.32-785.0 µg mL -1 for BEZ and AMD, respectively. The limits of detection (LOD) were 0.18 µg mL −1 for BEZ and 0.12 µg mL −1 for AMD and the limits of quantification (LOQ) were 0.59 µg mL −1 for BEZ and 0.41 µg mL −1 for AMD showed good sensitivity of the proposed method.
Accuracy and precision
The precision and accuracy of the method were determined by analysis of seven samples for drugs mixture. Intra-day assay variation was evaluated by injecting these samples in replicates of five in the same day. Inter-day assay variation was evaluated by injecting these samples in replicates of five on 5 different days from 1 to 21 after preparation. The relative standard deviation and recovery of different amounts tested were determined. Good recovery of the drugs was obtained at each concentration, indicating that the method was accurate. The resultant % RSD for this study was found to be < 2.0 % with a corresponding percentage recovery value. The recoveries obtained by RP-HPLC method for BEZ and AMD shown in Table 4 . The accuracy of the method is indicated by the excellent recovery. The results of repeatability (method precision) experiment are shown in Table 4 . The developed method was found to be precise as the % RSD values for repeatability study was < 2.0 %. The results of intermediate precision experiment for both intra-day and inter-day are shown in Table 4 . Replicate analyses of the concentrations of the standard solution show good reproducibility. The precision of the method is supported by the low relative standard deviation, as recorded in Table 4 . 
Robustness
The robustness of an analytical procedure is a measure of its capacity to remain unaffected by small, but deliberate variations in method parameters and provides an indication of its reliability during normal usage. Robustness of the method was investigated under a variety of conditions including change of formic acid concentration, flow rate and percentage of methanol in the mobile phase. The standard solution is injected in three replicates and sample solution of 100% concentration is prepared and injected in triplicate for every condition and RSD% of assay was calculated for each condition. The degree of reproducibility of the results obtained as a result of small deliberate variations in the method parameters has proven that the method is robust as shown in Table 5 .
Analysis of benazepril and amlodipine in capsule
The proposed method was applied for determination of BEZ and AMD in their pharmaceutical formulations (Figure 7) . The results of analysis of the commercial dosage forms are shown in Table 6 . The average percent recoveries obtained, indicated good accuracy of the method. The results obtained for the analysis of the studied drugs in drug formulations employed were compared with those obtained with the reference method [5] , (Table 6 ). The Student t-test and F-test values of 95% confidence level for five degrees of freedom [48] did not exceed the theoretical values indicating no significant difference between the accuracy and the precision of the two methods. The proposed method has the advantages of being virtually free from interferences by excipients or from common degradation products. ) and the internal standard, RIS (150 g mL -1 ) in the mobile phase, prepared from Amlopril capsules. Chromatographic conditions: C 8 column; mobile phase: 0.1 M formic acid and methanol (37:63, v/v); flow rate 0.9 mL min -1 and detection at 242 nm. supplied by National company and e supplied by K.C. Pharma, Syria.
CONCLUSION
A novel HPLC method was successfully developed and validated for the simultaneous determination of benazepril hydrochloride and amlodipine besylate. Method validation results have proved the method to be selective, precise, accurate, robust and stability-indicating. The method provided excellent specificity and linearity with limits of quantification of 0.59 and 0.41 g mL −1 and limits of detection of 0.18 and 0.12 g mL −1 for BEZ and AMD, respectively. The major advantage of this method is the wide range of linearity. Moreover, the lower solvent consumption along with the short analytical run time of 8 min as compared to sophisticated chromatographic techniques leads to an environmentally friendly chromatographic procedure, which makes it especially suitable for routine quality control analysis work with no interference of formulations excipients in the estimation.
